In addition, a significantly higher proportion of CD4+ T cells, CD8+ T cells, memory B cells, and M1 macrophages were found in patients in the low-risk group, indicating that there is a greater proportion of T cells and B cells in low-risk CRC tumors. This evidence concerns the gene CD4 and colorectal carcinoma.